FXN and neoplasm: Our data not only indicated that MRPS16 activated the PI3K/AKT/Frataxin axis to facilitate tumour cell proliferation, migration and invasion but also that MRPS16 activated PI3K/AKT signalling, which promoted Frataxin protein expression and promoted LAUD progression.